Brief: Argenica Therapeutics Says It Received Binding Commitments To Raise A$5.5 Mln
03/06/2022 01:08
June 3 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* RECEIVED BINDING COMMITMENTS TO SUCCESSFULLY RAISE A$5.5M
* FUNDING WILL ENABLE CO TO ACCELERATE PRECLINICAL
ACTIVITIES IN
ADDITIONAL APPLICATIONS, AMONG OTHERS
* PLACEMENT AT AN ISSUE PRICE OF A$0.40 PER SHARE
Source text for Eikon: ID:nASX2Nc1yP
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M